OR

Browse By

Targeting metstatic breast cancer by oligonucleotide therapeutics with the FDA lipid nanoparticles (LNP) delivery system. (2024–2027)

Grant type:
National Breast Cancer Foundation Investigator Initiated Research Scheme
Researchers:

  • Dr Behnam Rashidieh

    Honorary Research Fellow
    Mater Research Institute-UQ
    Faculty of Medicine
    Honorary Research Fellow
    Mater Research Institute-UQ
    Faculty of Medicine

  • Honorary Professor Kum Kum Khanna

    Honorary Professor
    Mater Research Institute-UQ
    Faculty of Medicine
    Honorary Professor
    Mater Research Institute-UQ
    Faculty of Medicine
Funded by:
National Breast Cancer Foundation